Emcure Pharmaceuticals reported a strong 36% year-on-year growth in its consolidated net profit to ₹292.5 crore for the June quarter of fiscal year 2027. The sharp surge in profitability was primarily spearheaded by robust growth in its international business segments. Investors closely tracked the operational performance metrics amid steady global expansion initiatives.